{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:47:48Z","timestamp":1792896468019,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013129","name":"Korea Ministry of SMEs and Startups","doi-asserted-by":"publisher","award":["RS-2023-00282845"],"award-info":[{"award-number":["RS-2023-00282845"]}],"id":[{"id":"10.13039\/501100013129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["RS-2022-NR070744"],"award-info":[{"award-number":["RS-2022-NR070744"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["KFRM24A0105L1"],"award-info":[{"award-number":["KFRM24A0105L1"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["KFRM25A0107L1"],"award-info":[{"award-number":["KFRM25A0107L1"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jconrel.2025.114420","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T11:47:08Z","timestamp":1763639228000},"page":"114420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Thioketal-linked glycol chitosan nanosystem for targeted and sustained drug delivery of mesalazine in inflammatory bowel disease"],"prefix":"10.1016","volume":"389","author":[{"given":"Chaerim","family":"Yoo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taekyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu Kyung","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyerim","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2025.114420_bb0005","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.1016\/j.cgh.2021.03.021","article-title":"A systematic review of monogenic inflammatory bowel disease","volume":"20","author":"Nambu","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2023.07.001","article-title":"Recent advances in the treatment of IBD: targets, mechanisms and related therapies","volume":"71-72","author":"Liu","year":"2023","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2025.114420_bb0015","first-page":"13","article-title":"Immunopathogenesis of IBD: current state of the art, nature reviews","volume":"13","author":"de Souza","year":"2016","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0020","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nrgastro.2015.150","article-title":"The global burden of IBD: from 2015 to 2025","volume":"12","author":"Kaplan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0025","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0030","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2468-1253(19)30333-4","article-title":"The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"5","author":"Collaborators","year":"2020","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0035","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3702518","article-title":"Smart nanoparticles for drug delivery application: development of versatile nanocarrier platforms in biotechnology and nanomedicine","volume":"2019","author":"Lombardo","year":"2019","journal-title":"J. Nanomater."},{"key":"10.1016\/j.jconrel.2025.114420_bb0040","doi-asserted-by":"crossref","first-page":"33081","DOI":"10.1021\/acsami.4c05214","article-title":"The role of nanoparticle morphology on enhancing delivery of budesonide for treatment of inflammatory bowel disease","volume":"16","author":"Li","year":"2024","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2025.114420_bb0045","doi-asserted-by":"crossref","first-page":"31169","DOI":"10.1021\/acsnano.5c09985","article-title":"Mucoadhesive and self-assembled chitosan oligosaccharide-glycyrrhizin nanoparticle for Oral Nanotherapeutic in inflammatory bowel disease","volume":"19","author":"Lim","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2025.114420_bb0050","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1021\/acsabm.4c01579","article-title":"Zwitterionic, stimuli-responsive liposomes for curcumin drug delivery: enhancing M2 macrophage polarization and reducing oxidative stress through enzyme-specific and hyperthermia-triggered release","volume":"8","author":"Basak","year":"2025","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2025.114420_bb0055","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/ibd\/izy123","article-title":"Nanoparticle-based oral drug delivery systems targeting the colon for treatment of ulcerative colitis","volume":"24","author":"Zhang","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.jconrel.2025.114420_bb0060","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1021\/acs.molpharmaceut.0c01245","article-title":"Smart responsive quercetin-conjugated glycol chitosan prodrug micelles for treatment of inflammatory bowel diseases","volume":"18","author":"Shen","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2025.114420_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.201900610","article-title":"A proresolving peptide nanotherapy for site-specific treatment of inflammatory bowel disease by regulating proinflammatory microenvironment and gut microbiota","volume":"6","author":"Li","year":"2019","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2025.114420_bb0070","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.3390\/molecules22101662","article-title":"Versatile chemical derivatizations to design glycol chitosan-based drug carriers","volume":"22","author":"Kim","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.jconrel.2025.114420_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2022.12.044","article-title":"Harnessing polymer-derived drug delivery systems for combating inflammatory bowel disease","volume":"354","author":"Pu","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2025.114420_bb0080","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3390\/polym14040687","article-title":"Applications of the ROS-responsive thioketal linker for the production of smart nanomedicines","volume":"14","author":"Rinaldi","year":"2022","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2025.114420_bb0085","series-title":"Medical Therapy of Ulcerative Colitis","first-page":"69","article-title":"Contrast and comparison of Mesalamine derivatives in the treatment of ulcerative colitis","author":"Mudireddy","year":"2014"},{"key":"10.1016\/j.jconrel.2025.114420_bb0090","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejpb.2021.07.014","article-title":"Mesalazine and inflammatory bowel disease \u2013 from well-established therapies to progress beyond the state of the art","volume":"167","author":"Veloso","year":"2021","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2025.114420_bb0095","first-page":"893","article-title":"The role of mesalamine in the treatment of ulcerative colitis","volume":"3","author":"Karagozian","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2025.114420_bb0100","doi-asserted-by":"crossref","DOI":"10.1093\/rb\/rbae122","article-title":"Curcumin-incorporated EGCG-based nano-antioxidants alleviate colon and kidney inflammation via antioxidant and anti-inflammatory therapy","volume":"11","author":"Pan","year":"2024","journal-title":"Regenerat. Biomater."},{"key":"10.1016\/j.jconrel.2025.114420_bb0105","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2249.1998.00728.x","article-title":"Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines","volume":"114","author":"Dieleman","year":"1998","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0110","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.tetlet.2015.07.059","article-title":"Synthesis of a reactive oxygen species responsive heterobifunctional thioketal linker","volume":"56","author":"Ling","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.jconrel.2025.114420_bb0115","first-page":"164","article-title":"Colon drug delivery Systems for the Treatment of inflammatory bowel disease","volume":"2","author":"Reda","year":"2019","journal-title":"J. Adv. Biomed. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2025.114420_bb0120","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11120-009-9439-x","article-title":"Fourier transform infrared (FTIR) spectroscopy","volume":"101","author":"Berthomieu","year":"2009","journal-title":"Photosynth. Res."},{"key":"10.1016\/j.jconrel.2025.114420_bb0125","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1021\/j150620a033","article-title":"Critical micelle concentration and the transition point for micellar size distribution","volume":"85","author":"Ruckenstein","year":"1981","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jconrel.2025.114420_bb0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.biomaterials.2018.10.010","article-title":"ROS-sensitive thioketal-linked polyphosphoester-doxorubicin conjugate for precise phototriggered locoregional chemotherapy","volume":"188","author":"Pei","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2025.114420_bb0135","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1177\/0885328219845081","article-title":"Thioketal-crosslinked: ROS-degradable polycations for enhanced in vitro and in vivo gene delivery with self-diminished cytotoxicity","volume":"34","author":"Zheng","year":"2019","journal-title":"J. Biomater. Appl."},{"key":"10.1016\/j.jconrel.2025.114420_bb0140","doi-asserted-by":"crossref","first-page":"9176","DOI":"10.1039\/C7OB01975K","article-title":"A ROS-responsive polymeric micelle with a \u03c0-conjugated thioketal moiety for enhanced drug loading and efficient drug delivery","volume":"15","author":"Sun","year":"2017","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.jconrel.2025.114420_bb0145","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1039\/D0CS01061H","article-title":"Stimulus-cleavable chemistry in the field of controlled drug delivery","volume":"50","author":"Xue","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2025.114420_bb0150","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0010-4655(95)00042-E","article-title":"GROMACS: a message-passing parallel molecular dynamics implementation","volume":"91","author":"Berendsen","year":"1995","journal-title":"Comput. Phys. Commun."},{"key":"10.1016\/j.jconrel.2025.114420_bb0155","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.softx.2015.06.001","article-title":"GROMACS: high performance molecular simulations through multi-level parallelism from laptops to supercomputers","volume":"1-2","author":"Abraham","year":"2015","journal-title":"SoftwareX"},{"key":"10.1016\/j.jconrel.2025.114420_bb0160","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/jcc.20291","article-title":"GROMACS: fast, flexible, and free","volume":"26","author":"Van Der Spoel","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2025.114420_bb0165","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/jcc.23354","article-title":"CHARMM36 all-atom additive protein force field: validation based on comparison to NMR data","volume":"34","author":"Huang","year":"2013","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jconrel.2025.114420_bb0170","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1021\/acs.jctc.7b00028","article-title":"How molecular size impacts RMSD applications in molecular dynamics simulations","volume":"13","author":"Sargsyan","year":"2017","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.jconrel.2025.114420_bb0175","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1016\/S0006-3495(97)78804-0","article-title":"Molecular dynamics study of unbinding of the avidin-biotin complex","volume":"72","author":"Izrailev","year":"1997","journal-title":"Biophys. J."},{"key":"10.1016\/j.jconrel.2025.114420_bb0180","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1063\/1.1590311","article-title":"Free energy calculation from steered molecular dynamics simulations using Jarzynski\u2019s equality","volume":"119","author":"Park","year":"2003","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jconrel.2025.114420_bb0185","series-title":"Introduction to Comsol Multiphysics\u00ae","author":"Multiphysics","year":"1998"},{"key":"10.1016\/j.jconrel.2025.114420_bb0190","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3390\/pharmaceutics13111862","article-title":"Compartmental and COMSOL multiphysics 3D modeling of drug diffusion to the vitreous following the administration of a sustained-release drug delivery system","volume":"13","author":"Dosmar","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2025.114420_bb0195","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10928-009-9142-8","article-title":"Selection between Michaelis\u2013Menten and target-mediated drug disposition pharmacokinetic models","volume":"37","author":"Yan","year":"2010","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.jconrel.2025.114420_bb0200","doi-asserted-by":"crossref","first-page":"17666","DOI":"10.1021\/la303449d","article-title":"Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes","volume":"28","author":"Nangia","year":"2012","journal-title":"Langmuir"},{"key":"10.1016\/j.jconrel.2025.114420_bb0205","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1021\/nl101140t","article-title":"Effect of nanoparticle surface charge at the plasma membrane and beyond","volume":"10","author":"Arvizo","year":"2010","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2025.114420_bb0210","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00210-014-0985-1","article-title":"Review article: the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases","volume":"387","author":"Piechota-Polanczyk","year":"2014","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0215","first-page":"193","article-title":"Abnormal barrier function in gastrointestinal disorders, gastrointestinal","volume":"239","author":"Farr\u00e9","year":"2017","journal-title":"Pharmacology"},{"key":"10.1016\/j.jconrel.2025.114420_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.761981","article-title":"Interaction between commensal bacteria, immune response and the intestinal barrier in inflammatory bowel disease","volume":"12","author":"Chen","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0225","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/MPG.0000000000001411","article-title":"Intestinal organoids: new frontiers in the study of intestinal disease and physiology","volume":"64","author":"Wallach","year":"2017","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jconrel.2025.114420_bb0230","doi-asserted-by":"crossref","first-page":"20170217","DOI":"10.1098\/rstb.2017.0217","article-title":"Intestinal organoids for modelling intestinal development and disease","volume":"373","author":"Fair","year":"2018","journal-title":"Philos. Trans. R. Soc. B"},{"key":"10.1016\/j.jconrel.2025.114420_bb0235","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/mi.2016.14","article-title":"Gut mucosal DAMPs in IBD: from mechanisms to therapeutic implications","volume":"9","author":"Boyapati","year":"2016","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0240","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.593969","article-title":"Intestinal morphogenesis in development, regeneration, and disease: the potential utility of intestinal organoids for studying compartmentalization of the crypt-villus structure","volume":"8","author":"Kwon","year":"2020","journal-title":"Front. Cell Develop. Biol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0245","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1146\/annurev-immunol-030409-101323","article-title":"HMGB1 is a therapeutic target for sterile inflammation and infection","volume":"29","author":"Andersson","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0250","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1021\/acs.jmedchem.7b01136","article-title":"High mobility group Box-1 (HMGb1): current wisdom and advancement as a potential drug target","volume":"61","author":"VanPatten","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jconrel.2025.114420_bb0255","doi-asserted-by":"crossref","first-page":"6878","DOI":"10.1038\/srep06878","article-title":"Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNA","volume":"4","author":"Yoon","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2025.114420_bb0260","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/bm800276d","article-title":"Why is chitosan mucoadhesive?","volume":"9","author":"Sogias","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2025.114420_bb0265","first-page":"893","article-title":"The role of mesalamine in the treatment of ulcerative colitis","volume":"3","author":"Karagozian","year":"2007","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.jconrel.2025.114420_bb0270","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.mayocp.2018.09.013","article-title":"Mechanisms of disease: inflammatory bowel diseases","volume":"94","author":"Ramos","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.jconrel.2025.114420_bb0275","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1734-1140(11)70575-8","article-title":"Treatment of inflammatory bowel disease (IBD)","volume":"63","author":"Pithadia","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.jconrel.2025.114420_bb0280","article-title":"Treatment of inflammatory bowel disease: a comprehensive review","volume":"8","author":"Cai","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.jconrel.2025.114420_bb0285","article-title":"Emerging treatments for inflammatory bowel disease","volume":"11","author":"Hazel","year":"2020","journal-title":"Therap. Adv. Chronic Dis."},{"key":"10.1016\/j.jconrel.2025.114420_bb0290","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0016-5085(99)70182-4","article-title":"Mesalamine blocks tumor necrosis factor growth inhibition and nuclear factor \u03baB activation in mouse colonocytes","volume":"116","author":"Kaiser","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2025.114420_bb0295","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1111\/j.1572-0241.2000.03360.x","article-title":"Mesalazine inhibits activation of transcription factor NF-\u03baB in inflamed mucosa of patients with ulcerative colitis","volume":"95","author":"Bantel","year":"2000","journal-title":"Offl. J. Am. College Gastroenterol.| ACG"},{"key":"10.1016\/j.jconrel.2025.114420_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1200111","article-title":"The role of Nrf2 in the pathogenesis and treatment of ulcerative colitis","volume":"14","author":"Peng","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2025.114420_bb0305","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/adhm.201200423","article-title":"Current progress in reactive oxygen species (ROS)-responsive materials for biomedical applications","volume":"2","author":"Lee","year":"2013","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2025.114420_bb0310","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016836592501034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:39:20Z","timestamp":1781325560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016836592501034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":62,"alternative-id":["S016836592501034X"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114420","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thioketal-linked glycol chitosan nanosystem for targeted and sustained drug delivery of mesalazine in inflammatory bowel disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2025.114420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114420"}}